ANAHEIM, CA / ACCESSWIRE / March 28, 2017 / BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady Granier, BioCorRx CEO, President, and Director, appeared as a guest on Fox Business Network’s “Mornings with Maria” this morning to discuss the nation’s opioid epidemic and the use of naltrexone for treatment.

“Mornings with Maria” features anchor, Maria Bartiromo alongside a roundtable of rotating industry titans and economic experts discussing the major news and themes driving the business day and the market moves. You can view the segment here: http://video.foxbusiness.com/v/5375919263001/?#sp=show-clips.

About BioCorRx

BioCorRx Inc. (OTCQB: BICX) is an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx® Recovery Program, a non-addictive, medication-assisted treatment (MAT) program, consists of two main components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers the non-addictive medicine, naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids. The second component of the program developed by BioCorRx Inc. is a one-on-one counseling program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. The Company also has an R&D subsidiary, BioCorRx Pharmaceuticals, which is currently developing a new injectable naltrexone technology (BICX101) through a partnership with TheraKine Ltd. The company plans to seek FDA approval for BICX101 and/or its naltrexone implant product(s). For more information on BICX, visit www.BioCorRx.com.

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words
“believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks
as well as uncertainties. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may
achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date
hereof.

BioCorRx Inc.

investors@BioCorRx.com
714-462-4880

Investor Relations:

Crescendo Communications, LLC
(212) 671-1020 x304
bicx@crescendo-ir.com

SOURCE: BioCorRx Inc.

ReleaseID: 458338

OKLAHOMA CITY, OK / ACCESSWIRE / March 28, 2017 / Medically Minded, Inc. (OTC PINK: MMHC) now named Medically Minded Holding Corp. and to be renamed Sixty Six Oilfield Services, LLC announces that it has added Mr. Gary Holley as an Advisor to the Board. Mr. Holley has been in the oil and gas drilling industry for 36 years, first at Parker Drilling Company, Tulsa, Oklahoma, until 1993, then to President and COO of Cougar Drilling Company in 1997. In 2008, Mr. Holley was Senior Vice President of Drilling Operations for NOMAC Drilling and in January 2009 Mr. Holley was promoted to President. In July 2009 Mr. Holley left NOMAC and was named President and CEO of Canyon Drilling Company. In 2015, Mr. Holley left Canyon and began his own consulting company, lending his vast experience to top Drilling Contractors Worldwide.

James Frazier, President and Chief Financial Officer of the Company, said: Mr. Holley has been a long time friend of the Company’s principal stockholders and we welcome him as an advisor. His experience and knowledge of the industry is invaluable. Mr. Holley will be working closely with our team, as we expand our operations in the heavy oilfield equipment marketplace worldwide.

On March 27, 2017, the Company filed its annual list with Nevada to restore its good standing. The Company plans to file a Certificate of Amendment with Nevada on or about March 28, 2017 to change its name and increase its authorized common stock. After the amendment is accepted, the Company intends to submit an application to FINRA for announcement of its name change and for a new ticker symbol to reflect its new name.

The Company is planning to publish its Rule 15c2-11 Information Statement for the fiscal year ended December 31, 2016 not later than March 31 at www.microcapreporting.com. The Companys financial statements will reflect the exchange of its Series A-1 Preferred stock for the members interest in 66 Oilfield Services, LLC completed March 14, 2017 as a reverse merger.

SAFE HARBOR AND INFORMATIONAL STATEMENT

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of among other things: (i) the Company’s financing plans; (ii) trends affecting the Company’s financial condition or results of operations; (iii) the Company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may”, “would”, “will”, “expect”, “estimate”, “anticipate”, “believe”, “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the Company’s reports filed with the SEC. The Company is not eligible to rely on the safe harbor provided by Section 21E(c) of the Exchange Act because it is not subject to filing periodic reports under Sections 13 or 15(d) of the Exchange Act.

For more information, contact:

Jim Frazier, President, Jim@66oilfield.com
info@66oilfield.com
405.735.6666
855. DRL.PIPE (375-7473)

Only information that is publicly available will be provided.

SOURCE: Medically Minded, Inc.

ReleaseID: 458337

VANCOUVER, BC / ACCESSWIRE / March 28, 2017 / Pistol Bay Mining Inc. (OTC PINK: SLTFF) (TSX-V: PST) (FSE: OQS2) (“Pistol Bay” or the “Company”) is pleased to report that the Company has entered into an amending agreement with Rio Tinto Exploration Canada Inc. (“RTECI” or “Rio Tinto”), with regards to the C 4, 5 and 6 Uranium properties, whereby Rio Tinto will make an initial cash payment of $750,000 to Pistol Bay.

The C block of Uranium properties, located in the Athabasca Basin of Saskatchewan, is under option to Rio Tinto, which has earned a 75-per-cent interest to date. Rio Tinto has previously indicated its intention to exercise the further option to acquire a 100-percent interest by paying Pistol Bay $5-million on or before Dec. 31, 2019, and granting Pistol Bay a 5-per-cent net profit interest (see Pistol Bay news release of Feb. 16, 2015).

Under the amending agreement, Rio Tinto will acquire an additional 25% interest in the Property (thereby increasing its aggregate interest to 100%), by:

(a) paying Pistol Bay $750,000 on or before April 17, 2017; and

(b) paying Pistol Bay one of the following payments:

(i) $1,500,000 on or before 31 December 2017;
(ii) $2,000,000 on or before 31 December 2018; or
(iii) $2,250,000 on or before 31 December 2019.

Pistol Bay will retain a 5% net profits interest in the Property.

Charles Desjardins, CEO of Pistol Bay, commented: “Rio Tinto’s payment does not dilute the Company and allows Pistol Bay to expand the scope of its upcoming exploration work, including drilling, on its Confederation Lake greenstone belt zinc-copper-gold project. We look forward to continuing our working relationship with Rio Tinto.”

About Pistol Bay Mining Inc.

Pistol Bay Mining Inc. is a diversified junior Canadian mineral exploration company with a focus on precious and base metal properties in North America. For additional information please contact Charles Desjardins – pistolbaymining@gmail.com.

On Behalf of the Board of Directors
PISTOL BAY MINING INC.

“Charles Desjardins”
Charles Desjardins,
President and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary note:

This report contains forward-looking statements. Resource estimates, unless specifically noted, are considered speculative. Any and all other resource or reserve estimates are historical in nature, and should not be relied upon. By their nature, forward-looking statements involve risk and uncertainties because they relate to events and depend on factors that will or may occur in the future. Actual results may vary depending upon exploration activities, industry production, commodity demand and pricing, currency exchange rates, and, but not limited to, general economic factors. Cautionary Note to US investors: The U.S. Securities and Exchange Commission specifically prohibits the use of certain terms, such as “reserves” unless such figures are based upon actual production or formation tests and can be shown to be economically and legally producible under existing economic and operating conditions.

SOURCE: Pistol Bay Mining Inc.

ReleaseID: 458340

Upcoming AWS Coverage on Sabra Health Care REIT Post-Earnings Results

LONDON, UK / ACCESSWIRE / March 28, 2017 / Active Wall St. blog coverage looks at the headline from Senior Housing Properties Trust (NASDAQ: SNH) as the Company announced on March 27, 2017, that it has formed a joint venture with a sovereign institutional investor to acquire 11 Fan Pier and 50 Northern Avenue in Boston, MA. Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

One of Senior Housing Properties Trust’s competitors within the REIT – Healthcare Facilities space, Sabra Health Care REIT, Inc. (NASDAQ: SBRA), reported on February 22, 2017, its fourth quarter 2016 results. AWS will be initiating a research report on Sabra Health Care REIT in the coming days.

Today, AWS is promoting its blog coverage on SNH; touching on SBRA. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/register/

Senior Housing Properties is a real estate investment trust, which owns senior living communities, medical office buildings and wellness centers throughout the US. The Company is managed by the operating subsidiary of The RMR Group Inc., an alternative asset management company that is headquartered in Newton, MA.

Transaction Detail

Senior Housing stated that the investor will contribute approximately $261 million for a 45% equity interest in the new venture, and Senior Housing Properties will own the remaining 55% equity interest. The investment amount is based on a property valuation of $1.2 billion, less $620 million of existing secured debt on the property.

The property included in the joint venture was acquired by Senior Housing Properties in May 2014 for $1.125 billion, consisting of two 15-storey, class A LEED® Gold Certified life-science buildings with structured parking located in Boston’s Seaport District. The two buildings are 95% leased to Vertex Pharmaceuticals, Inc. through 2028 and include 1.1 million rentable square feet of lab, corporate office and street level retail space.

Senior Housing Properties expects to use the cash proceeds from this transaction to repay a portion of the amounts outstanding under its revolving credit facility.

David Hegarty, the Company’s President and Chief Operating Officer stated:

“We are pleased to announce SNH’s first joint venture transaction to own property. This transaction highlights the increased value of these two well located, well leased buildings since we acquired them less than three years ago. This transaction also reduces our investment portfolio’s concentration in this property and reduces our overall leverage.”

Ownership Control

Senior Housing Properties stated that it will continue to control the acquired property because its partner in this joint venture is a passive financial investor. Accordingly, the Company expects to consolidate the operating results of this venture in its financial statements and expects to account for the investor’s minority equity interest in the venture as a non-controlling interest for financial reporting purposes. Senior Housing Properties noted that it is subject to a confidentiality agreement and cannot disclose the identity of the investor that formed this joint venture with the Company.

Stock Performance

At the close of trading session on Monday, March 27, 2017, Senior Housing Properties Trust’s stock price rose slightly by 0.85% to end the day at $20.28. A total volume of 2.03 million shares were exchanged during the session, which was above the 3-month average volume of 1.57 million shares The stock has surged 13.30% and 19.73% in the last three months and past twelve months, respectively. Furthermore, since the start of the year, shares of the Company have gained 7.13%. The stock currently has a market cap of $4.81 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458332

LAS VEGAS, NV / ACCESSWIRE / March 28, 2017 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC PINK: CBAI) (“CBAI” or the “Company”) today announced financial results for the fourth quarter and fiscal year 2016.

Highlights Include:

Total revenue for the fourth quarter 2016 was $0.73 million, a decrease of 33.9% from total revenue of $1.11 million for the fourth quarter 2015. Total revenue for the year ended December 31, 2016 was $3.29 million, a decrease of 37.1% from total revenue of $5.23 million for the year ended December 31, 2015.
Recurring storage revenue for the fourth quarter 2016 was $0.68 million, an increase of 4.6% from recurring storage revenue of $0.65 million for the fourth quarter 2015. Recurring storage revenue for the year ended December 31, 2016 was $2.71 million, an increase of 3.3% from recurring storage revenue of $2.62 million for the year ended December 31, 2015.
EBITDA for the fourth quarter 2016 was negative $0.10 million compared to EBITDA of $0.10 million for the fourth quarter 2015. EBITDA for the year ended December 31, 2016 was $0.27 million compared to EBITDA of $0.76 million for the year ended December 31, 2015.

Results of Operations for the Three-Months Ended December 31, 2016

For the three-months ended December 31, 2016, total revenue was $0.73 million, a decrease of $0.38 million or 33.9% from $1.11 million in fourth quarter 2015. Of the $0.38 million decrease, $0.27 million was attributable to the ceasing of orders in March 2016 within the tissue procurement business and $0.03 million was attributable to the reduction in storage and processing revenue from a previously terminated agreement with a third party. As of December 2016, the Company ceased storing samples for this third party and expects no processing and storage revenue going forward.

Gross Profit for the three-month period ended December 31, 2016 was $0.54 million, a decrease of $0.16 million or 22.7% from $0.70 in fourth quarter 2015. Of the $0.16 million decrease, approximately $0.10 million was attributable to the tissue procurement business, and approximately $0.03 million was attributable to the reduction in storage and processing revenue from the third party.

Gross Margin for the three-month period ended December 31, 2016 was 74.1% compared to 63.3% in fourth quarter 2015. Gross margin increased due to the reduction in revenue from lower margin business and reductions made by the Company in cost of goods sold.

Net income for the three-month period ended December 31, 2016 was $0.002 million compared to net income of $0.02 million for the period ended December 31, 2015. Included in fourth quarter 2016 net income was severance expense of $0.04 million related to the Company’s former President and a one-time charge of $0.19 million taken for the remaining severance payable as of December 31, 2016. Going forward, the Company will no longer incur severance expense related to the former President.

EBITDA for the three-month period ending December 31, 2016 was a loss of $0.10 million compared to $0.10 million in fourth quarter 2015. Excluding the $0.23 million of total severance expense and $0.01 million of expense associated with the strategic review process incurred in the quarter, EBITDA would have been $0.14 million, a $0.04 million increase compared to $0.10 million in fourth quarter 2015 despite the reduction in revenue as the Company continues to reduce costs to offset the loss in revenue.

Results of Operations for the Fiscal Year 2016

For the year ended December 31, 2016, total revenue was $3.29 million, a decrease of $1.94 million or 37.1% from $5.23 million in fiscal 2015. Of the $1.94 million decrease, $1.56 million was attributable to the ceasing of tissue procurement orders and $0.22 million was attributable to the reduction in storage and processing revenue from the third party.

Gross Profit for fiscal year 2016 was $2.38 million, a decrease of $0.98 million or 29.1% compared from $3.36 million in fiscal 2015. Of the $0.98 million decrease, approximately $0.69 million was attributable to the tissue procurement business, and approximately $0.15 million was attributable to the reduction in storage and processing revenue from the third party.

Gross Margin for fiscal year 2016 was 72.5% compared to 64.3% in fiscal 2015. Gross margin increased due to the reduction in revenue from lower margin business and reductions made by the Company in cost of goods sold.

Net income for fiscal year 2016 was $0.10 million compared to net income of $0.44 million for fiscal 2015. Included in 2016 net income was severance expense of $0.13 million related to the Company’s former President and a one-time charge of $0.19 million taken in the fourth quarter for the remaining severance payable as of December 31, 2016. Going forward, the Company will no longer incur severance expense related to the former President.

EBITDA for fiscal year 2016 was $0.26 million compared to $0.76 million in fiscal 2015. Excluding the $0.32 million of total severance expense and $0.04 million of expense associated with the strategic review process incurred during the fiscal year, EBITDA would have been $0.62 million compared to $0.76 million in fiscal 2015.

Commentary and Update on Strategic Review Process

Chairman, David Sandberg stated, “While 2016 saw significant reduction in revenue from the unforeseen loss of tissue procurement orders and the ending of a third-party storage and processing agreement, the Company was able to significantly reduce costs which mitigated the impact on EBITDA and cash flow. Given the cost base entering 2017 and the assumption that the Company will continue to add new samples which has occurred year-to-date, we see the opportunity to increase EBITDA to the range of $175,000 to $200,000 per quarter, excluding any one-time charges, for fiscal 2017. Q1’17 results should reflect some or much of this progress.”

Chairman, David Sandberg further stated, “After a lengthy strategic review process, the Board was unable to execute a sale of the business. While the Board received letters of intent to acquire the Company or assets of the Company, we believe larger bidders did not focus on and execute a reasonable timeline to close given the relatively small size of the Company, and smaller bidders encountered difficulty securing financing which delayed the process. The Board, in consultation with the Company’s financial advisor, Boxwood Partners, LLC, made the decision to discontinue sale talks with both after having been engaged in negotiations for a lengthy period of time. We continue to have high level discussions regarding mergers and acquiring other related businesses that may have high cash synergies without increased complexity. I’d personally like to thank our employees and Board for what has been a busy 2016 – we cut significant costs in tandem with revenue declines, but samples continue to grow, debt is nearly fully repaid, and the Company is in a net cash position which we expect to grow. The Company may consider a share repurchase so as to offer liquidity to those shareholders seeking it, but a rights offering or some form of equity raise also remains an option if or when opportunities arise which we believe would increase shareholder value and require additional funding to close. The current business is small but otherwise healthy and sound.”

Non-GAAP Measures

In addition to the GAAP financial measures set forth in this press release, the Company has included the non-GAAP measurement EBITDA which presents operating results on a basis adjusted for depreciation, amortization, interest expense and taxes. The Company uses this non-GAAP measure as a key performance measure for the purpose of evaluating performance internally. The Company also believes this non-GAAP measure provides our investors with useful information regarding our operating results. This non-GAAP measure is not intended to replace the presentation of our financial results in accordance with GAAP. Use of the term EBITDA may differ from similar measures reported by other companies.

About Cord Blood America, Inc.

Cord Blood America, Inc. is the parent company of CorCell Companies, Inc. which, along with Cord Blood America, Inc., facilitates umbilical cord blood and cord tissue stem cell processing and storage for expectant parents and their children. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. and CorCell Companies, Inc., visit our websites: http://www.cordblood-america.com/ for investor information and http://www.corcell.com/ for customer information.

Forward-Looking Statements

Some statements made in this press release are forward-looking statements. We use words such as “anticipate,” “believe,” “expect,” “future,” “intend,” “plan,” and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and Cord Blood America’s performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company’s public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company’s past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

Investor Contact:

Anthony Snow
asnow@cordblood-america.com

SOURCE: Cord Blood America, Inc.

ReleaseID: 458269

Upcoming AWS Coverage on Westmoreland Coal

LONDON, UK / ACCESSWIRE / March 28, 2017 / Active Wall St. blog coverage looks at the headline from Dominion Diamond Corp. (NYSE: DDC) as the Company announced on March 27, 2017, that its Board of Directors has formed a Special Committee to explore, review and evaluate multiple potential strategic alternatives, primarily aimed at maximizing shareholder’s value. The Special Committee will work together with the Company’s management team and advisors to explore alternatives that could include the sale of the Company or other strategic transactions. Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

One of Dominion Diamond’s competitors within the Nonmetallic Mineral Mining space, Westmoreland Coal Co. (NASDAQ: WLB), announced on March 16, 2017, that it is delaying the filing of its Form 10-K with the SEC for the period ended December 31, 2016, as well as its previously scheduled earnings release and teleconference, until Tuesday, March 28, 2017. AWS will be initiating a research report on Westmoreland Coal in the coming days.

Today, AWS is promoting its blog coverage on DDC; touching on WLB. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/register/

Details of the Agreement

Dominion Diamond is a Canadian diamond mining Company with ownership interests in two major diamond producing located approximately 200 kilometres south of the Arctic Circle in Canadian’s Northwest Territories. The Company operates the Ekati Diamond Mine and holds 40% ownership of the Diavik Diamond Mine which is jointly owned by Rio Tinto PLC (NYSE: RIO).

Currently, Dominion Diamond supplies rough diamonds to the global market through its sorting and selling operations across Belgium, India, and Canada, as the largest independent diamond producer.

A source close to Rio said last week that it was not interested in selling its stake in Diavik, even if US Billionaire Dennis Washington was interested in acquiring it.

The $1.1 billion Unsolicited Bid

On March 19, 2017, Dominion Diamond confirmed that it had received an unsolicited, conditional, and non-binding expression of interest from the Washington Corporation to acquire the Company for approximately $1.1 billion. The offer was initially not accepted owing to Washington’s lack of expertise in the diamond mining and processing industry, and a lack of a proper business strategy to maintain the Company’s growth.

This transfer of power and strategic secrets was not in the best of interest of the shareholders and hence, the Company remained confident on its long-term strategic plan and the opportunity it offers to enhance the value delivered to shareholders. Dominion Diamond stated in its official press release that it is open to holding discussions with Washington Corporation on customary terms and in a manner that protects the interests of the Company and its stakeholders.

FY18 Guidance

Dominion Diamond announced on March 16, 2017, its guidance for FY18, ending January 31, 2018. The Company expects the sales to be in the range of $875 million and $975 million, representing a 62% increase from its FY17 sales. Adjusted EBITDA is expected to be in the range of $475 million to $560 million for FY18. The cash cost of production is expected to be in the range of $70-$80 per ton processed with $35-$45 per carat produced. Dominion forecasts net production from its Ekati and Diavik Gold Mines to be between 9.1 million to 10.0 million carats, which includes 100% contribution from Ekati Mine and 40% from Diavik Mine for FY18

Additionally, the Company announced that it expects the Lynx project to start commercial production of high-value carats in FY18 at the Ekati location, while the Sable project would have first production of high-value carats in FY20.

Considering the announcement of exploration of strategic opportunities, the Company’s Board of Directors has not set a fixed schedule for this process nor has made any decisions related to strategic alternatives at this time. Hence, there is no assurance offered that the exploration of strategic alternatives will result in any transaction or change in strategy.

Stock Performance

On Monday, March 27, 2017, the stock closed the trading session at $12.93, rising slightly by 1.65% from its previous closing price of $12.72. A total volume of 2.28 million shares have exchanged hands, which was higher than the 3-month average volume of 425.85 thousand shares. Dominion Diamond’s stock price surged 47.43% in the last month, 39.18% in the past three months, and 42.28% in the previous six months. . Furthermore, since the start of the year, shares of the Company have rallied 33.57%. The stock has a dividend yield of 3.09%. The net market capital for the Company stood at $1.07 billion at yesterday’s closing bell.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458311

Upcoming AWS Coverage on RealPage Post-Earnings Results

LONDON, UK / ACCESSWIRE / March 28, 2017 / Active Wall St. announces its post-earnings coverage on Alarm.Com Holdings, Inc. (NASDAQ: ALRM). The Company disclosed its financial results for the fourth quarter fiscal 2016 (Q4 FY16) and full year fiscal 2016 (FY16) on March 15, 2017. The Tysons Corner, Virginia-based Company’s quarterly total revenues increased 23% y-o-y, outperforming market consensus estimates. Register with us now for your free membership at:

http://www.activewallst.com/register/

One of Alarm.Com Holdings’ competitors within the Application Software space, RealPage, Inc. (NASDAQ: RP), reported on February 28, 2017, its financial results for the fourth quarter and year ended December 31, 2016. AWS will be initiating a research report on RealPage in the coming days.

Today, AWS is promoting its earnings coverage on ALRM; touching on RP. Get our free coverage by signing up to:

http://www.activewallst.com/register/

Earnings Reviewed

Alarm.com reported total revenues of $69.79 million in Q4 FY16, which came in above $56.92 million in Q4 FY15. Total revenue numbers for Q4 FY16 topped market forecasts of $64 million. Meanwhile, the Company’s SaaS and license revenue grew 21% to $46.89 million in Q4 FY16 from $38.69 million in Q4 FY15. Furthermore, revenues from hardware and other revenue rose to $22.91 million in Q4 FY16 from $18.23 million in Q4 FY15.

The security and remote monitoring system maker’s net income attributable to common stockholders for Q4 FY16 came in at $2.97 million, or $0.06 per diluted share, compared to $3.27 million, or $0.07 per diluted share, in Q4 FY15. Meanwhile, the Company reported non-GAAP adjusted net income attributable to common stockholders of $9.06 million, or $0.19 per diluted share, in Q4 FY16 versus $6.59 million, or $0.14 per diluted share in Q4 FY15. Wall Street had expected the Company to report non-GAAP adjusted net income of $0.13 per diluted share.

In FY16, Alarm.com’s revenues came in at $261.11 million, up 25% from $208.89 million in the previous year. The Company reported net income attributable to common stockholders of $10.14 million, or $0.21 per diluted share, in FY16 versus net loss attributable to common stockholders of $7.22 million, or $0.30 loss per diluted share, in FY15. Furthermore, the Company’s non-GAAP adjusted net income attributable to common stockholders during FY16 was $31.13 million, or $0.65 per diluted share, compared to $7.07 million, or $0.27 per diluted share, in FY15.

Operating Metrics

Alarm.com spent $38.93 million as operating expenses in Q4 FY16 compared to $32.09 million in Q4 FY15. The Company’s reported operating income of $4.15 million in Q4 FY16 compared to $4.73 million in the prior year’s same period. Furthermore, the Company’s adjusted EBITDA surged in the reported quarter to $14.31 million from $9.77 million in Q4 FY15.

Cash Flow and Balance Sheet

In twelve months ended December 31, 2016, net cash provided by the Company’s operating activities fell to $17.50 million from $27.14 million in FY15. As on December 31, 2016, the Company had cash and cash equivalents balance of $140.63 million compared to a balance of $128.36 million as on December 31, 2015. The Company’s long-term debt stood constant at $6.70 million as on December 31, 2016, compared to the long-term debt figures as on December 31, 2015.

Acquisition Spree

On March 13, 2017, Alarm.com announced the acquisition of substantially all of ObjectVideo Inc.’s business, including the Company’s products, technology portfolio and personnel. The business, now called ObjectVideo Labs, is a leader in providing advanced research and engineering services for federal government customers.

Earlier on March 08, 2017, the Company announced that it has completed its previously announced acquisition of two business units, Connect and Piper, from Icontrol Networks.

Earnings Outlook

In its guidance for full year FY17, Alarm.com’s total revenue is projected to be in the range of $322 million to $325.5 million. Additionally, the Company expects SaaS and license revenue during FY17 to be in the range of $231 million to $232.5 million, while hardware and other revenue for the year is projected to be in the range of $91 million to $93 million. Adjusted EBITDA for FY17 is forecasted to be between $65 million and $66 million with non-GAAP adjusted net income in the range of $36 million to $37 million.

For Q1 FY17, the Company expects SaaS and license revenue to be in the range of $49.3 million to $49.5 million.

Stock Performance

On Monday, March 27, 2017, the stock closed the trading session at $30.33, falling 2.32% from its previous closing price of $31.05. A total volume of 470.84 thousand shares have exchanged hands, which was higher than the 3-month average volume of 248.35 thousand shares. Alarm.Com Holdings’ stock price rallied 11.10% in the last three months, 12.54% in the past six months, and 37.43% in the previous twelve months. Furthermore, since the start of the year, shares of the Company have surged 8.98%. At Monday’s closing price, the stock’s net capitalization stands at $1.42 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458333